Health department outlines FY27 budget priorities, workforce cuts and program shifts

The Vermont Department of Health (VDH) presented its FY27 governor‑recommended budget to the Senate Appropriations Committee, describing a roughly $221 million topline (a 1.2% decrease from FY26) and a set of programmatic and appropriation shifts to address an identified shortfall.

VDH fiscal staff told the committee the department expects initial licensure and fee revenue estimates for another agenda bill and walked the committee through major appropriations for health. The department proposed discontinuing an unused drug-repository program after failing to find a vendor willing to repack unused medications; that program was identified as a straightforward near-term savings.

VDH also proposed program reductions in workforce development: it flagged a proposed reduction of approximately $4.1 million in the Health Professionals Educational Assistance (loan‑repayment) program (largely used for nursing) and about $550,000 in support for Area Health Education Centers (AHEC). Department leaders and committee members discussed whether Rural Health Transformation Program (RHTP) funds (discussed as a sizable federal grant for workforce, roughly characterized in committee discussion) could replace loan-repayment dollars; VDH emphasized RHTP cannot be used for loan repayment under federal rules and that RHTP is not a like‑for‑like replacement.

Megan Hope (financial director, VDH) summarized appropriation-line movements and position changes: VDH’s administrative appropriation shows 59 positions in FY27 compared with 62 in FY26 due to internal reclassifications, and public-health appropriations show a net reduction of three positions (with some federal COVID–supplement positions ending). The department also requested increased spending authority for the Vermont Vaccine Purchasing Program (roughly a 7.5% increase in program cost) to reflect higher vaccine costs, funded by an insurer assessment deposited in a special fund.

On substance-use programming, VDH proposed moving Narcan distribution and syringe‑services activity into the Substance Use appropriation and described an increase in prevention funding driven by cannabis excise revenues; the administration estimated roughly $9.5 million for the substance‑misuse prevention fund in FY27. VDH described the Vermont Prevention Lead Organization (VPLO) structure and asked the committee for more time to produce outcome and return‑on‑investment metrics for prevention investments.

Why it matters: The VDH FY27 proposal contains internal appropriation shifts, some near-term program eliminations and workforce‑focused reductions that have implications for health workforce recruitment and service delivery. Committee members requested additional data about program impacts and alternatives before accepting workforce reductions.

Next steps: VDH committed to provide additional analysis on workforce impacts, comparative data on RHTP versus existing loan‑repayment programs, and metrics quantifying prevention program benefits as follow‑up to committee requests.